baber/WOPTO huggingface dataset:
Patent DE-69900553-T2 (DE)
Inventor: WEBER WOLFGANG
IPC: B29C65/00
Filed: 1999-03-23
Granted: 2002-08-01
Abstract: The invention disclosed hereunder is a process and a device for the preparation and formation of a plastic weld connection between a workpiece (13) and a second component to be attached thereto by heating by means of a heating device (12). If force is applied, the heating element (12) tends to deform the contact surface especially in the case of hollow, thin-walled workpieces such as plastic containers. So far, methods were disclosed for the measuring of the degree of deformation by means of a sensor, subsequently readjusting the position of the heating device according to the determined deformation. The invention disclosed here under dispenses with any measurement of deformation, instead using an elastic element which automatically readjusts the position of the heating element (12) in the case of deformation of the workpiece (13) to effect a pre-load between the heating device (12) positioned at the contact surface of the work-piece (13) and the workpiece (13).
Patent DE-69906546-T2 (DE)
Inventor: SANDERSON KEVIN DAVID
IPC: C23C16/40
Filed: 1999-07-29
Granted: 2003-12-24
Abstract: A process for coating glass with a layer of tungsten oxide comprising directing a gaseous stream containing tungsten oxyhalide or tungsten chloride and a source of oxygen onto the surface of a glass substrate. Preferably, the source of oxygen comprises an ester, in particular an ester having from 3 to 6 carbon atoms. The gaseous stream may additionally contain a source of fluorine to form fluorine doped tungsten oxide layers.
Patent DE-69908425-T2 (DE)
Inventor: MISCHENKO VALENTIN ALEXANDROVI
IPC: G07D7/20
Filed: 1999-12-08
Granted: 2004-05-06
Abstract: A method for marking comprises applying a unique image ( 3 ) on to the surface of the article or a label. The surface for applying an image should have a rough texture. The applied image is scanned by the scanner ( 6 ) and encoded. The code ( 4 ) is applied on to the label next to the image. The code data and the image data are transferred to the remote control center. Authentication is performed at the checking terminals located in public.
Patent DE-69917883-T2 (DE)
Inventor: LARSON A
IPC: A61P11/00
Filed: 1999-11-08
Granted: 2005-06-02
Abstract: The present invention relates to pharmaceutical compositions for the sustained release of pharmacologically active compounds, and methods of their manufacture and use. The pharmaceutical compositions contain microcrystals of pharmacologically active compounds which are encapsulated within a phospholipid layer which contain a unique combination of phospholipids. The pharmaceutical compositions may be rendered suitable for injection. The microcrystals are of varying sizes. At least 50 percent of the microcrystals are from 0.5 mum and 3.0 mum in diameter, at least ten percent of the microcrystals are from 3.0 mum to 10 mum in diameter, and the composition may contain microcrystals which are greater than 10 mum in diameter. Methods of manufacturing the composition are disclosed, as well as various methods of administration.
Patent DE-69918130-T2 (DE)
Inventor: GENTALEN ERIK
IPC: C12Q1/6874
Filed: 1999-08-19
Granted: 2005-07-07
Abstract: The invention provides arrays of polynucleotide probes having at least one pooled position. A typical array comprises a support having at least three discrete regions. A first region bears a pool of polynucleotide probes comprising first and second probes. A second region bears the first probe without the second probe and a third region bears the second probe without the first probe. A target nucleic acid having segments complementary to both the first and second probes shows stronger normalized binding to the first region than to the aggregate of binding to the second and third regions due to cooperative binding of pooled probes in the first region. The invention provides methods of using such arrays for e.g., linkage analysis, sequence analysis, and expression monitoring.
Patent DE-69918159-T2 (DE)
Inventor: MOUSSY FRANCIS
IPC: A61L27/54
Filed: 1999-11-19
Granted: 2005-03-17
Abstract: A generic implantable puck that can be used with a number of biosensor configurations. This generic implantable potentiostat telemetry unit (the puck) can also be part of a system to detect glucose concentrations. An electrochemical system partially implantable into a body for detecting glucose concentrations therein is presented. The system comprises an electrochemical sensor, a transmitting puck including an electric circuit connected to the electrochemical sensor for transmitting a signal indicative of the glucose concentrations in the body. There is at least one receiver for receiving the signal from the transmitting puck and a computer system coupled tlo the at least one receiver for processing the signal for patient diagnosis and treatment.
Patent DE-69927139-T2 (DE)
Inventor: BROOKER J
IPC: A61M16/00
Filed: 1999-03-05
Granted: 2006-06-14
Abstract: A pulmonary dosing system and method for supplying to a patient a predetermined amount of respirable therapeutically active material. The system comprises a patient interface to introduce the material into the patient's lungs. The patient interface is connected to a flexible inhalation tube and a flexible exhalation tube. The exhalation tube is connected to a filter having an outlet connected to atmosphere. The inhalation tube is connected to an apparatus for providing pulsed amounts of the material entrained in filtered atmospheric air. A control unit operates the pulmonary dosing system in accordance with operator inputs regarding the number of patent exhales between pulses, and pulse length. The exhaust filter and the apparatus for providing pulsed amounts of the therapeutically active material may be enclosed in a containment case and the patient's interface may comprise a mouth tube-mask combination when the therapeutically active material comprises at least one toxic drug.
Patent DE-69928797-T2 (DE)
Inventor: LEE ALAN
IPC: G05D23/19
Filed: 1999-05-17
Granted: 2006-08-10
Abstract: The use of incubation means for the controlled heating of biological materials, said means comprising an electrically conducting polymer connectable to a power supply, said polymer being either contiguous or integral with an incubation vessel, or adapted to be in thermal contact with an incubation vessel. Incubation apparatus including such means and a method for culturing biological materials using them are also described and claimed.
Patent DE-69935424-T2 (DE)
Inventor: GONZALEZ DE PRADO DIAZ JOSE LU
IPC: H04W72/04
Filed: 1999-06-25
Granted: 2007-12-13
Abstract: Method for multiple access in a radiocommunication system which avoids forming a signalling multiframe with an inflexible turn of transmission. A fixed unit (11-j) broadcasts over a pilot channel a predetermined number of virtual identities for signalling which form the signalling multiframe, so that when a remote unit wishes to transmit, it selects one of the virtual identities received.  The time slots in the signalling multiframe are distributed among those remote units (12-1 to 12-m) which have signalling messages to transmit to the fixed unit (11-j).  <IMAGE>
Patent HU-E027679-T2 (HU)
Title: Compounds derived from herbicidal carboxylic acids and tetraalkylammonium or (arylalkyl) trialkylammonium hydroxides
Inventor: KRAMER VINCENT J
IPC: A01N39/04
Filed: 2008-02-26
Abstract: Compounds formed by combining a carboxylic acid herbicide with N-((C 1 - C 16 ) alkyl or arylalkyl) tri((C 1 -C 16 ) alkyl)ammonium hydroxide have herbicidal activity on an acid equivalent basis at least as active as the commercially used carboxylic acid herbicide salts, but are less volatile.
Patent MD-3393478-T2 (MD)
Inventor: GRIFFITH HUGH
IPC: A61P35/00
Filed: 2016-12-21
Abstract: Această invenţie se referă la o combinaţie de gemcitabină- [fenil-benzoxi-L-alaninil)] - fosfat (denumire chimică: 2'-Deoxy-2 ', 2'-difluoro-D-citidină-5'-0- [fenil ( benzoxi- L-alaninil)] fosfat) (NUC-1031) şi un agent anticancer bazat pe platină selectat dintre cisplatină, picoplatină, lipoplatină şi triplatină. Combinaţiile sunt utile în tratamentul cancerului şi în special a cancerului vezicii biliare şi vezicii urinare.
Patent MD-3583120-T2 (MD)
Inventor: CHEN XIAOCHENG
IPC: C07K14/79
Filed: 2018-02-15
Abstract: Sunt furnizate aici polipeptide care se leagă la un receptor de transferină, metode de generare a unor astfel de polipeptide şi metode de utilizare a polipeptidelor pentru a ţinti o compoziţie către o celulă care exprimă receptorul de transferină.
Patent TR-200200456-T2 (TR)
Title: Bir elektrik temin düzeneği.
Inventor: SINCLAIR JOHN ASHTON
IPC: H01R25/14
Filed: 2000-07-27
Abstract: Flençlerle birbirine baglanmis çok sayida enine nervürden olusan uzunlamasina bir esnek iletken. Flençler, iletkene elektriksel olarak baglanacak bir cihazin pimine geçecek sekildedir. Iletkeni, düzenli araliklarda delikleri olan uzunlamasina bir esnek yalitici çevrelemektedir. Iletkenin içinden hava akisini saglamak için eklenmis olan delikler, iletkenin sogutulmasina yardimci olmaktadir.
Patent TR-200201293-T2 (TR)
Inventor: VANDENBUSSCHE FR D RIC
IPC: C04B20/06
Filed: 2000-10-31
Abstract: The invention concerns a method for making expanded clay granules, characterized in that the granules are expanded by being heated with microwave radiation.
Patent DE-602004010943-T2 (DE)
Inventor: DEQUI ERIC
IPC: G06F13/42
Filed: 2004-03-11
Granted: 2009-01-02
Abstract: The system has a management station periodically transmitting a start message (19) on a multiplexed network. The message is transmitted until reception by stations connected to the network, in response to detection of start request (17) and end of initialization period (18). The management station transmits a frame of start state (21) until expiry of a time period (22) determined after the transmission of the start message. The management station integrated in a vehicle transmits a frame of normal functioning state (23) after expiry of the time period.
Patent DE-602004010976-T2 (DE)
Inventor: DAMM GERARD
IPC: H04L12/56
Filed: 2004-08-24
Granted: 2009-01-08
Abstract: A disjoint graph structure for packet classification in communication systems is presented. The disjoint graph is comprised of two types of data structures; an elementary interval tree (EIT) and a disjoint interval tree (DIT). The disjoint graph is constructed based on a range-specified rule set finding particular application in the classification of data packets. Each rule in the rule set has an equal number of fields and each field specifies a range referred to as an integer interval having a lower and an upper bound. The disjoint graph has the same number of layers as there are fields in each rule. The layers are comprised of nodes, and each node has an associated rule set selected from the range-specified rule set The disjoint graph enables packet classification in only one pass through the tree. The EIT and DIT structures are also presented in detail. <IMAGE>
Patent DE-602004011615-T2 (DE)
Inventor: GOULDING MARK JOHN
IPC: C09K19/32
Filed: 2004-06-30
Granted: 2009-01-29
Abstract: The invention relates to novel 9- and/or 10-substituted anthracenes, to their use in liquid crystal, light-emitting or semiconducting materials and devices, in anisotropic polymers, optical, electrooptical, decorative, security, cosmetic, diagnostic, electric, electronic, charge transport, semiconductor, optical recording, electroluminescent, photoconductor or electrophotographic applications, and to liquid crystal, light-emitting and semiconducting materials, polymers and devices comprising them.
Patent DE-602004012745-T2 (DE)
Inventor: BHASKARAN SUNIL
IPC: A61K31/198
Filed: 2004-05-13
Granted: 2009-04-09
Abstract: A composition for the treatment of diabetes in a subject in need thereof, said composition—comprising Trigonelline of concentration ranging between 20 to 30%, amino acids of concentration ranging between 20 to 60%, and soluble fiber of concentration ranging between 10 to 60%, optionally along with pharmaceutically acceptable additives, a process thereof and also, a method of treating diabetes.
Patent DE-602005004420-T2 (DE)
Inventor: CAO YANG
IPC: C12Q1/533
Filed: 2005-07-28
Granted: 2009-01-08
Abstract: The present invention relates to a novel and useful method for assaying compounds and agents for their ability to decrease or inhibit the activity of hematopoietic prostaglandin D2 synthase (hPGDS). Specifically, the present invention relates to assays for measuring the potency, specificity and toxicity of hPGDS inhibitors.
Patent DE-69416090-T3 (DE)
Inventor: DUSSAUSSE JEAN-PAUL
IPC: H01R4/24
Filed: 1994-11-16
Granted: 2006-06-01
Abstract: The asymmetric contact comprises a first terminal part for connection to an external conductor and a second terminal part for elastically connecting to another similar contact. It is characterised in that the said second terminal part (4) is axially off-centred with respect to the first terminal part (1, 2, 3) and with respect to the part (8) coupling these parts together and has a width substantially half that of the said first terminal part. Application: terminal strip for computer local networks. <IMAGE>
Patent DK-1207876-T3 (DK)
Inventor: PRENZEL NORBERT
IPC: A61P35/00
Filed: 2000-08-16
Granted: 2011-10-10
Abstract: The present invention relates to agents and methods for growth-factor receptor activation by modulating the G-protein mediated signal transduction pathway.
Patent DK-1206602-T3 (DK)
Inventor: SAMUELSSON BERTIL
IPC: E02D29/02
Filed: 2000-08-17
Granted: 2005-01-31
Abstract: A retaining wall consists of wall blocks (1) forming tiers on top of one another, so that the blocks in each tier are displaced laterally relative to the blocks in over-lying and under-lying tiers a distance comprising half the length of a wall block, said wall blocks comprising a front surface (4) and a rear surface (5), a top surface (2) and a bottom surface (3) spaced apart from one another a distance which determines the thickness of the block (1), first and second end surfaces (6, 7), at least one recess (16, 17) provided in the block (1), said recess extending upwards into the block from the bottom surface (3). The recess has a rear wall (16a, 17a), a recess ceiling (17e), an outer side wall (16b, 17b), and an inner side wall (16c, 17c). At least one pin aperture (39, 39', 43, 43') extends into at least all the blocks beneath the top tier of blocks at right angle to the top surface of the blocks, said pin apertures being located such that its centre line (C) extends through the region of a rear outer corner (29, 19) of said recess or through a point at a distance from said corner in a direction towards the rear side of the block, which distance is not greater than the extension of the pin aperture in the said direction, and that in all the tiers of wall blocks, except of the blocks in the top tier a pin is inserted in said pin aperture, a portion of the pin extending beyond the top surface (2) of the wall block, said projecting pin portion lying flush against the rear wall of a wall block of an over-lying tier of wall blocks.
Patent DK-1270154-T3 (DK)
Inventor: YEH WEN-YA
IPC: B26B13/24
Filed: 2001-06-21
Granted: 2004-09-06
Abstract: A both hand hair cutting method is for hairdressers to hold proper tools, such as scissors, razors, electric cutters, plural scissors, in a right hand and a left hand to perform cutting at the same time or not at the same time, depending on personal hair quality, hair quantity, length and needed styles. The lower levels of the right side and the left side of hair can be cut to have the same directions, and cutting the angle of hair, combing hair, and trimming the lower ends of hair can be easily performed by a hairdresser according to this method. The hairdresser is not disturbed by the head shape, the ears, the shoulders, and the hair length of a customer. The hair can be cut and with fastness, enabling the finished hair style to look soft, natural and beautiful.
Patent DK-1272204-T3 (DK)
Inventor: HUARD JOHNNY
IPC: A61P17/00
Filed: 2001-04-12
Granted: 2007-09-10
Abstract: The present invention provides muscle-derived progenitor cells (MDCs) that show long-term survival following transplantation into body tissues and which can augment soft tissue following introduction into a site of soft tissue. Also provided are methods of isolating MDCs. The invention further provides methods of using compositions comprising MDCs for the augmentation and bulking of mammalian, including human, soft tissues in the treatment of various cosmetic or functional conditions, including malformation, injury, weakness, disease, or dysfunction. The invention also relates to uses of MDCs for the treatment of cosmetic or functional conditions, including, but not limited to skeletal muscle weakness, muscular dystrophy, muscle atrophy, spasticity, myoclonus and myalgia. The invention also relates to the novel use of MDCs for the increase of skeletal muscle.
Patent DK-1294874-T3 (DK)
Inventor: HSU YEN-MING
IPC: A61P19/08
Filed: 2001-06-08
Granted: 2006-08-28
Abstract: Methods of decreasing (e.g., inhibiting) the expression of wildtype CD154 on the surface of a target cell and methods of treating a patient suffering from or predisposed to a CD154-mediated disease. In these methods, a nucleic acid construct that directs expression of a mutant CD154 lacking at least a portion of the tumor necrosis factor homologous domain ("TNFH") is introduced into a target cell (such as a T helper cell or a cytotoxic T cell). The expressed mutant CD154 binds to wildtype CD154 inside the cell, rendering the wildtype protein unable to reach the cell surface.
Patent DK-1319790-T3 (DK)
Inventor: ANGLHUBER HUBERT
IPC: E06B1/00
Filed: 2002-11-21
Granted: 2009-11-16
Abstract: The anchor structure for a door or window frame is a combination of slabs (1,2), an insulation layer (3), and side units (4) at the ends of the slabs in their recesses and preferably the coverings or frames. The insulation layer between the slabs prevents the transfer of heat and/or sound and/or mechanical loading. The side units are bonded to the slabs by at least one anchor (5), with at least one mounting for the side units. The slabs are preferably prefabricated concrete slabs for fixed constructions.
Patent DK-1302205-T3 (DK)
Inventor: WADHWA HARDEEP
IPC: A61K9/22
Filed: 2002-10-01
Granted: 2005-08-08
Abstract: Disclosed is an oral controlled release macrolide pharmaceutical formulation. In a preferred embodiment, the formulation comprises a citrate salt of a preferred macrolide, clarithromycin. Also disclosed are methods for preparing, isolating and characterizing soluble and stable citrate salt of macrolides and use thereof in all solid dosage forms of macrolides.
Patent DK-1327710-T3 (DK)
Inventor: BONTEMPS GUY
IPC: D02G3/18
Filed: 2002-12-30
Granted: 2004-11-29
Abstract: The cut-resistant yarn consists of a multifilament extruded glass core (A1), generally of silionne or basalt glass, and an outer covering sleeve of wound filaments (B1) of a thermoplastic or thermo-setting polymer, or a natural or synthetic elastomer which is optionally fluoridated. The glass fibre core comprises up to 60 wt.% and it can incorporate composite or synthetic fibres.
Patent DK-1416803-T3 (DK)
Inventor: KOKA RATHNA
IPC: A23C21/02
Filed: 2002-05-07
Granted: 2007-11-05
Abstract: Process for manufacturing cheeses and other dairy products, and the resulting products, in which lactobionic acid is added, or generated in situ, in combination with a dairy component in the course of the process. The lactobionic acid can be used as the sole acidulent for direct acidification of the cheese, or in conjunction with reduced amounts of lactic acid culture. When the lactobionic acid is generated in situ during cheese manufacture according to the invention, a lactose oxidase is used in one embodiment to convert lactose intrinsically present in the dairy liquid ingredient(s) into lactobionic acid. The organoleptic attributes of the cheeses made using lactobionic acid as an ingredient are satisfactory and fully suitable. The process can be applied to the production of a wide variety of cheeses, including, for example, cream cheeses, hard cheeses such as cheddar, UF cheeses, process cheeses, cheddar cheeses, and so forth.
Patent DK-1454150-T3 (DK)
Inventor: BALZ CHRISTOPH
IPC: G01R13/00
Filed: 2002-12-12
Granted: 2006-03-13
Abstract: Method for graphical depiction of the I and Q components of digitally modulated high frequency signals in which the sequentially measured and I and Q components are simultaneously graphically displayed on a display device (8).  An Independent claim is included for a system for graphical display of I and Q components.
Patent DK-1422975-T3 (DK)
Inventor: DOWLING KEVIN
IPC: H05B37/02
Filed: 2001-04-24
Granted: 2010-08-02
Abstract: A lighting device comprising: at least one LED; and a power converter coupled to the at least one LED and configured to provide DC power to the at least one LED, characterised in that the power converter is configured to receive power, from a dimming control, in the form of a variable amplitude AC signal or a chopped AC waveform, and convert the received power into DC power for the at least one LED.
Patent DK-1377049-T3 (DK)
Inventor: YOUNG PATRICK
IPC: G06F3/023
Filed: 1991-09-10
Granted: 2006-12-11
Abstract: Screen (10) for a user interface of a television schedule system and process consists of an array (24) of irregular cells (26), which vary in length, corresponding to different program lengths of one half to one-and-one half hours or more. Because of the widely varying length of the cells (26), if a conventional cursor used to select a cell location were to simply step from one cell to another, the result would be abrupt changed in the screen (10). By restricting cursor movements to the regular cells, abrupt screen changes will be avoided. A conventional offset shadow (34) which is a black bar underlines the entire cell and wraps around the right edge of the cell. To tag the underlying position which defines where the cursor (32) is and thus, where it will move next portions (36) of the black bar outside the current underlying position are segmented, while the current position is painted solid.
Patent DK-1478424-T3 (DK)
Inventor: CRUMP CHET M
IPC: A61M16/10
Filed: 2003-01-24
Granted: 2008-05-13
Abstract: An endotracheal suction catheter apparatus is provided. The apparatus includes a distal end that is configured for allowing a catheter to be moved through the distal end and into the respiratory tract of a patient. The distal end defines a cleaning chamber where the catheter may be cleaned. A flap is located in the distal end and is located on one end of the cleaning chamber. The flap effects fluid flow within the cleaning chamber during cleaning of the catheter. A connection member is present and is attached to the distal end. The connection member is configured for releasably engaging a heat and moisture exchanger so that the catheter may be advanced through the distal end into the heat and moisture exchanger.
Patent DK-1496944-T3 (DK)
Inventor: WARRINGTON KENNETH H
IPC: C12N15/861
Filed: 2003-05-01
Granted: 2008-12-01
Abstract: Disclosed are methods of gene delivery using capsid-modified recombinant adeno-associated viral (rAAV) vectors. Exemplary methods are provided employing vectors that have altered affinity for heparin or heparin sulfate, as well as vectors, expression systems, and rAAV virions that lack functional VP2 protein expression, but are nevertheless, fully virulent. Also provided by the invention are methods employing the rAAV vector-based compositions, virus particles, host cells, and pharmaceutical formulations in the expression of selected therapeutic proteins, polypeptides, peptides, antisense oligonucleotides and/or ribozymes in selected mammals, including organs, tissues, and human host cells.
Patent DK-1629880-T3 (DK)
Inventor: WURZINGER RAINER
IPC: B01D53/50
Filed: 2004-11-08
Granted: 2009-06-15
Abstract: A tower (3) has at least two gas duct (12) inlets (2) at an angle calculated to provide a gas distribution pattern as the liquid droplets descend from spray jets at a higher level to ensure a long contact duration between the gas and liquid.